The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study

Background: The purpose of this study was to compare the results of the halo split skin graft (HSSG) by two primary care skin cancer practitioners at one clinic at the Gold Coast, Queensland, Australia, to the results of the only previous study while adding to the body of evidence regarding use of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Danika Fietz, Graham Sivyer, Denis O'Brien, Cliff Rosendahl
Formato:	article
Lenguaje:	EN
Publicado:	Mattioli1885 2013
Materias:	skin cancer halo graft non-melanoma skin cancer NMSC leg Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/658a3d59eadd4226b2a71bbce1ab40ee
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:658a3d59eadd4226b2a71bbce1ab40ee
record_format	dspace
spelling	oai:doaj.org-article:658a3d59eadd4226b2a71bbce1ab40ee2021-11-17T08:32:34ZThe halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study10.5826/dpc.0304a112160-9381https://doaj.org/article/658a3d59eadd4226b2a71bbce1ab40ee2013-10-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/931https://doaj.org/toc/2160-9381 Background: The purpose of this study was to compare the results of the halo split skin graft (HSSG) by two primary care skin cancer practitioners at one clinic at the Gold Coast, Queensland, Australia, to the results of the only previous study while adding to the body of evidence regarding use of the HSSG following excision of non-melanoma skin cancer on the leg. Method: A retrospective review of the notes (Jan 2010-Aug 2012) was performed of all cases of non-melanoma skin cancer (NMSC) excisions in which split skin graft (SSG) closure with the HSSG was utilized on the leg. Results: There were a total of 68 HSSGs included over the 31 months of the study. Average lesion size was 19.4 mm (range 9-75 mm) and the average age of patients was 78 years (range 49-95 years) with 49% of patients being male. The average healing time was 4 weeks with 35/68 (51%) healing within 14 to 21 days. The overall infection rate was 8/68 (11.8%), which decreased to 4/53 (7.5%) when the ankle grafts were excluded. The graft failure rate was 7/68 (10%) with 3/68 (4.4%) having both infection and graft failure. Limitations: This was a retrospective study. Conclusion: The HSSG confines the surgical wounds to a single site, does not require specialized equipment and it is an economical and effective option for managing NMSC on the leg in situations where skin graft is indicated. Danika FietzGraham SivyerDenis O'BrienCliff RosendahlMattioli1885articleskin cancerhalo graftnon-melanoma skin cancerNMSClegDermatologyRL1-803ENDermatology Practical & Conceptual (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	skin cancer halo graft non-melanoma skin cancer NMSC leg Dermatology RL1-803
spellingShingle	skin cancer halo graft non-melanoma skin cancer NMSC leg Dermatology RL1-803 Danika Fietz Graham Sivyer Denis O'Brien Cliff Rosendahl The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study
description	Background: The purpose of this study was to compare the results of the halo split skin graft (HSSG) by two primary care skin cancer practitioners at one clinic at the Gold Coast, Queensland, Australia, to the results of the only previous study while adding to the body of evidence regarding use of the HSSG following excision of non-melanoma skin cancer on the leg. Method: A retrospective review of the notes (Jan 2010-Aug 2012) was performed of all cases of non-melanoma skin cancer (NMSC) excisions in which split skin graft (SSG) closure with the HSSG was utilized on the leg. Results: There were a total of 68 HSSGs included over the 31 months of the study. Average lesion size was 19.4 mm (range 9-75 mm) and the average age of patients was 78 years (range 49-95 years) with 49% of patients being male. The average healing time was 4 weeks with 35/68 (51%) healing within 14 to 21 days. The overall infection rate was 8/68 (11.8%), which decreased to 4/53 (7.5%) when the ankle grafts were excluded. The graft failure rate was 7/68 (10%) with 3/68 (4.4%) having both infection and graft failure. Limitations: This was a retrospective study. Conclusion: The HSSG confines the surgical wounds to a single site, does not require specialized equipment and it is an economical and effective option for managing NMSC on the leg in situations where skin graft is indicated.
format	article
author	Danika Fietz Graham Sivyer Denis O'Brien Cliff Rosendahl
author_facet	Danika Fietz Graham Sivyer Denis O'Brien Cliff Rosendahl
author_sort	Danika Fietz
title	The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study
title_short	The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study
title_full	The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study
title_fullStr	The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study
title_full_unstemmed	The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study
title_sort	halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study
publisher	Mattioli1885
publishDate	2013
url	https://doaj.org/article/658a3d59eadd4226b2a71bbce1ab40ee
work_keys_str_mv	AT danikafietz thehalosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy AT grahamsivyer thehalosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy AT denisobrien thehalosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy AT cliffrosendahl thehalosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy AT danikafietz halosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy AT grahamsivyer halosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy AT denisobrien halosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy AT cliffrosendahl halosplitskingraftinthemanagementofnonmelanomaskincancerofthelegaretrospectivestudy
_version_	1718425675131518976

The halo split skin graft in the management of non-melanoma skin cancer of the leg: a retrospective study

Ejemplares similares